λ-Carrageenan improves the antitumor effect of dendritic cellbased vaccine.

about

λ-Carrageenan improves the antitumor effect of dendritic cellbased vaccine.

Item

http://www.wikidata.org/entity/Q41853661

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

λ-Carrageenan improves the antitumor effect of dendritic cellbased vaccine.

@en

type

Item

label

λ-Carrageenan improves the antitumor effect of dendritic cellbased vaccine.

@en

prefLabel

λ-Carrageenan improves the antitumor effect of dendritic cellbased vaccine.

@en

P1476

λ-Carrageenan improves the antitumor effect of dendritic cellbased vaccine.

@en

P2093

Adila Aipire

http://www.w3.org/2001/XMLSchema#string

Chunling Liu

http://www.w3.org/2001/XMLSchema#string

Hongge Zhu

http://www.w3.org/2001/XMLSchema#string

Jia Yang

http://www.w3.org/2001/XMLSchema#string

Jinyao Li

http://www.w3.org/2001/XMLSchema#string

Jinyu Li

http://www.w3.org/2001/XMLSchema#string

Wenjia Guo

http://www.w3.org/2001/XMLSchema#string

Xiaoqin Li

http://www.w3.org/2001/XMLSchema#string

Yanping Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Myeloid-derived suppressor cells as regulators of the immune system

Carrageenan as an adjuvant to enhance peptide-based vaccine potency

Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer.

FOXP3 defines regulatory T cells in human tumor and autoimmune disease.

CpG DNA as a vaccine adjuvant.

Antitumor and Adjuvant Activity of λ-carrageenan by Stimulating Immune Response in Cancer Immunotherapy

Synergistic effect of κ-carrageenan on oxazolone-induced inflammation in BALB/c mice.

Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity.

Altered maturation of peripheral blood dendritic cells in patients with breast cancer.

Altered macrophage differentiation and immune dysfunction in tumor development

P304

29996-30007

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.15610

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28404904

http://www.w3.org/2001/XMLSchema#string

P932

5444720

http://www.w3.org/2001/XMLSchema#string